In this engaging webinar with Synthego and Mission Bio, explore the revolutionary potential of CRISPR genome editing. CRISPR has ushered in a new era of research and precision medicine, offering targeted modifications in genetic sequences. However, the power of CRISPR comes with a complex challenge– edits often yield heterogeneous outcomes.
In this session, Travis Hardcastle, Product Manager at Synthego, and Brittany Enzmann, Product Manager at Mission Bio, delve into the intricacies of CRISPR editing and dissect the heterogeneity of editing outcomes and their implications. They explore the cutting edge in cell engineering, including automated gene editing on Synthego’s Eclipse platform to generate reproducible results and multi-guide RNA approaches for high efficiency knockouts and Mission Bio introduces a transformative single-cell assay for measuring CRISPR outcomes to dissect zygosity, co-occurrence, and off-target edits.
